Ocular Health Market Growth Strategy slide image

Ocular Health Market Growth Strategy

A 100% spinoff will be in the best interest of shareholders Alcon Alcon incorporated and headquartered in Switzerland; Fort Worth will continue to be a key location Dual listing on SIX Swiss Exchange and NYSE with one global share (Ticker: ALC) 1 Alcon share for every 5 Novartis shares / ADRs 1 Expected completion in Q2 2019 and earliest in April Novartis shareholders approved the spinoff at the 2019 Novartis Annual General Meeting on February 28. Completion remains subject to certain conditions precedents, such as no material adverse events and receipt of necessary authorizations 1. Any fractional interest will be compensated in cash 28
View entire presentation